AGP Executive Report
Last update: 3 hours agoMedicinal Cannabis Milestone (UK): A boy with severe epilepsy who helped change UK medicinal cannabis law is now thriving and seizure-free at 21, after cannabis-based treatment stopped hundreds of daily seizures. Clinical Safety & Prescribing Controls (Thailand): Thailand’s health authorities warn dentists not to pre-sign cannabis prescription forms without examining and diagnosing patients, citing potential legal and ethical breaches. Cardiovascular Study (US): A new study finds habitual cannabis users had about 9% fewer premature heartbeats on days they inhaled cannabis versus days they abstained, adding nuance to heart-risk questions. Regulated Market Access (Australia): ASX cannabis stocks Vitura Health, Little Green Pharma, Cann Group and ECS Botanics draw attention for operating details like distribution reach, regulatory execution and cultivation efficiency. Hemp Crackdown Fight (Hawaii): A dispensary owner challenges Hawaii’s crackdown on hemp-derived THC products sold without medical cards, arguing it improperly recriminalizes federally legal hemp. Aviation Drug Testing (India): Air India pilots face further scrutiny after additional preliminary drug-test failures tied to the Phuket-Delhi incident, with results pending confirmation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
